Recent Updates

May 2019

Foodlink Complete with Fibre powder sachets have been added to the formulary as an amber (specialist) option for patients who require an enhanced fibre oral nutritional supplement. Click here for more information.

  • AYMES Shake sachets have been removed

Dermatonics® Once Heel Balm (25% urea) has been added to the formulary as an amber (specialist) option for the treatment of callused, anhidrotic, fissured, and hard foot skin conditions. Click here for more information.

Flexitol® 25% Urea Heel Balm has been added to the formulary as an amber (specialist) option for the treatment of callused, anhidrotic, fissured, and hard foot skin conditions. Click here for more information.

Ganciclovir 0.15% w/w eye gel has been added to the formulary as an amber (specialist) option for acute herpetic keratitis (dendritic and geographic ulcers). Click here for more information.

  • Aciclovir 3% w/w eye ointment has been removed, following discontinuation from the worldwide market by the manufacturer.

Commissioning Policy: The routine commissioning of semaglutide is accepted in Devon for patients with type 2 diabetes as described for glucagon-like peptide-1 (GLP-1) mimetics in NICE guideline NG28 (see Commissioning Policy for more details). Semaglutide has been added in the formulary as a green (first line) option in line with the policy. Click here for more information

Commissioning Policy: The routine commissioning of FreeStyle Libre is accepted in Devon for patients with diabetes mellitus in line with specific criteria (see Commissioning Policy for more details). Click here for more information.

March 2019

Cilique (ethinylestradiol 35micrograms/ norgestimate 250micrograms) tablets have been added to the formulary as a green (first line) option for hormonal contraception. Click here for more information.

  • Cilest (ethinylestradiol 35micrograms/ norgestimate 250micrograms) tablets have been discontinued by the manufacturer and have been removed from the formulary

Cilodex (ciprofloxacin 3mg/ml & dexamethasone 1mg/ml) ear drops, suspension has been added to formulary as a blue (second line) option for acute otitis externa (AOE) in adults and children over 1 year of age. Click here for more information.

DEKAs Plus (liquid, chewable tablets, and softgels) and DEKAs Essential capsules have been added to the formulary as amber (specialist input) options for the dietary management of cystic fibrosis patients. Click here for more information.

Paravit-CF liquid has been added to the formulary as amber (specialist input) options for the dietary management of cystic fibrosis in babies and patients with swallowing difficulties. Click here for more information.

Lyme disease: Formulary guidance has been revised and updated. The updated guidance provides more detail including specific antibiotic recommendations depending on the patient's age and presenting symptoms. Please see the formulary for further guidance.

Management of gout: Formulary guidance has been revised and updated. Please see the formulary for further guidance.

Dexamfetamine drug entry has been updated to support and guide prescribers on the safe and effective use of the medication. Please see the formulary for further guidance.

January 2019

Cholurso® has been removed as the preferred brand of ursodeoxycholic acid 250mg tablets; generic prescribing is now recommended. Click here for more information.

Emollients: The choice of formulary emollient preparations has been updated with supporting guidance to aid prescribers. Click here for more information.

Prolongation of the QT interval: New guidance relating to drugs that prolong the QT interval has been developed and added to the cardiovascular chapter. Please see the formulary for further guidance.

Unipolar depression: NICE and Devon Partnership NHS Trust (DPT) prescribing guidelines have been used to revise and update formulary guidance. Please see the formulary for further guidance.

Palliative care opioid equivalency table has been updated and a link to the document hosted on the Rowcroft Hospice website has been added to the formulary.

 

Home > Formulary > Updates > Recent Updates

 

  • First line
  • Second line
  • Specialist
  • Hospital